|
US2259698A
(en)
|
1938-05-07 |
1941-10-21 |
Rare Chemicals Inc |
Physiologically effective substance and process of preparing same
|
|
US2594323A
(en)
|
1948-07-22 |
1952-04-29 |
Upjohn Co |
24-substituted delta 5-cholene-3, 24-diols
|
|
US2673206A
(en)
|
1950-06-07 |
1954-03-23 |
Schering Corp |
25-ethinyl steroids
|
|
US3079385A
(en)
|
1961-01-24 |
1963-02-26 |
Roussel Uclaf |
Novel process of preparation of polyhydroxylated pregnanes
|
|
US3206459A
(en)
|
1962-10-19 |
1965-09-14 |
Syntex Corp |
10alpha-pregnan-19-ol derivatives
|
|
JPS5324071B2
(sr)
|
1974-04-30 |
1978-07-18 |
|
|
|
US4071625A
(en)
|
1974-05-13 |
1978-01-31 |
Richardson-Merrell Inc. |
19-Oxygenated-5α-androstanes for the enhancement of libido
|
|
CH628907A5
(en)
|
1975-10-10 |
1982-03-31 |
Hoffmann La Roche |
Process for the preparation of 24,25-dihydroxycholesterol derivatives
|
|
JPS5840960B2
(ja)
|
1976-12-28 |
1983-09-08 |
帝人株式会社 |
ヒドロキシコレステロ−ル立体異性体間の相互変換法
|
|
US4183852A
(en)
|
1977-07-18 |
1980-01-15 |
Kaiser Emil T |
Process for preparing 25-hydroxycholesterol
|
|
JPS54163565A
(en)
|
1978-06-09 |
1979-12-26 |
Teijin Ltd |
24*255epoxyy3beta * 266 dihydroxyychlestoo55ene or protected derivative of hydroxyl group thereof and production
|
|
US4174345A
(en)
|
1978-08-01 |
1979-11-13 |
Kaiser Emil T |
Synthesis of steroids
|
|
US4269777A
(en)
|
1979-05-21 |
1981-05-26 |
Wisconsin Alumni Research Foundation |
Isotopically labeled vitamin D derivatives and processes for preparing same
|
|
JPS5735597A
(en)
|
1980-08-13 |
1982-02-26 |
Teijin Ltd |
25,26-epoxy-3beta,24-dihydroxycholest-5-ene or its hydroxyl- protected derivative and their preparation
|
|
US4358406A
(en)
|
1981-07-27 |
1982-11-09 |
Wisconsin Alumni Research Foundation |
26,26,26,27,27,27-Hexafluoro-1α,25-dihydroxycholecalciferol and process for preparing same
|
|
JPS61254599A
(ja)
|
1985-05-07 |
1986-11-12 |
Sumitomo Pharmaceut Co Ltd |
コレステロ−ルのフツ素誘導体
|
|
DE3664909D1
(en)
|
1985-05-30 |
1989-09-14 |
Taisho Pharmaceutical Co Ltd |
Vitamin d3 derivatives
|
|
JPS62187485A
(ja)
|
1986-02-13 |
1987-08-15 |
Teijin Ltd |
２４，２５−エポキシコレステロ−ル類の製造法
|
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
EP0382790A4
(en)
|
1987-08-25 |
1991-03-27 |
Kelvin W. Gee |
Compositions and methods for alleviating stress, anxiety and seizure activity
|
|
US5376645A
(en)
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
|
AU698834B2
(en)
|
1993-05-24 |
1998-11-12 |
Purdue Pharma Ltd. |
Methods and compositions for inducing sleep
|
|
IL110309A0
(en)
|
1993-07-15 |
1994-10-21 |
Univ Kentucky Res Found |
A method of protecting against neuron loss
|
|
DE4338316A1
(de)
|
1993-11-10 |
1995-05-11 |
Jenapharm Gmbh |
Neue Steroide mit radikophilen Substituenten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
PT752860E
(pt)
|
1994-02-14 |
2000-12-29 |
Euro Celtique Sa |
Androstanos e pregnanos para modulacao alosterica do receptor de gaba
|
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
|
US5595996A
(en)
|
1994-10-25 |
1997-01-21 |
Merck & Co., Inc. |
7-substituted 4-aza cholanic acid derivatives and their use
|
|
CZ292881B6
(cs)
|
1994-11-23 |
2003-12-17 |
Euro-Celtique S.A. |
Androstanová a pregnanová řada pro allosterickou modulaci GABA receptoru
|
|
JPH08268917A
(ja)
|
1995-03-31 |
1996-10-15 |
D D S Kenkyusho:Kk |
癌組織への移行性の高い制癌剤
|
|
FI974448A0
(fi)
|
1995-06-06 |
1997-12-05 |
Cocensys Inc |
Androstaani- ja pregnaanisarjan neuroaktiiviset steroidit
|
|
US5792635A
(en)
|
1995-06-07 |
1998-08-11 |
Magainin Pharmaceuticals, Inc. |
Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
|
|
US6645953B2
(en)
|
1995-06-23 |
2003-11-11 |
Novo Nordisk A/S |
Meiosis regulating compounds
|
|
DE69630802T2
(de)
|
1995-06-23 |
2004-08-12 |
Novo Nordisk A/S |
Meiose regulierende verbindungen.
|
|
US5888996A
(en)
|
1995-07-26 |
1999-03-30 |
Trustees Of Boston University |
Inhibition of NMDA receptor activity and modulation of glutamate-mediated synaptic activity
|
|
EP0840612A1
(en)
|
1995-07-24 |
1998-05-13 |
Trustees Of Boston University |
Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
|
|
US5841272A
(en)
|
1995-12-20 |
1998-11-24 |
Sundstrand Corporation |
Frequency-insensitive current sensor
|
|
AU3068497A
(en)
|
1996-05-06 |
1997-11-26 |
Bionumerik Pharmaceuticals, Inc. |
Process for preparing 27-hydroxy cholesterol and related derivatives
|
|
JPH09328498A
(ja)
|
1996-06-10 |
1997-12-22 |
Teijin Ltd |
２４，２５−ジヒドロキシコレステロールの製造法およびその合成中間体
|
|
WO1998005337A1
(en)
|
1996-08-01 |
1998-02-12 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
|
DE19635525A1
(de)
|
1996-08-20 |
1998-02-26 |
Schering Ag |
7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
|
|
US6122371A
(en)
|
1997-07-22 |
2000-09-19 |
Atwell; Ronald C. |
Apparatus for protecting coin-operated telephones from vandalism and larceny
|
|
EP1077933A1
(en)
|
1998-05-11 |
2001-02-28 |
Novo Nordisk A/S |
Substituted guanidines and diaminonitroethenes, their preparation and use
|
|
IL139241A0
(en)
|
1998-05-13 |
2001-11-25 |
Novo Nordisk As |
Meiosis regulating compounds
|
|
US8541600B2
(en)
|
1998-11-24 |
2013-09-24 |
Harbor Therapeutics, Inc. |
11-aza, 11-thia and 11-oxa sterol compounds and compositions
|
|
DE19917930A1
(de)
|
1999-04-15 |
2000-10-19 |
Schering Ag |
Ent-Steroide als selektiv wirksame Estrogene
|
|
CA2372342A1
(en)
|
1999-04-29 |
2000-11-09 |
Derk J. Hogenkamp |
3.alpha.-hydroxy-3.beta. methoxymethyl-21-heterocycle substituted steroids with anesthetic activity
|
|
US6376530B1
(en)
*
|
1999-05-10 |
2002-04-23 |
Merck & Co., Inc. |
Cyclic amidines useful as NMDA NR2B antagonists
|
|
GB9910934D0
(en)
|
1999-05-11 |
1999-07-14 |
Res Inst Medicine Chem |
Chemical compounds
|
|
CN1111167C
(zh)
|
1999-10-22 |
2003-06-11 |
中国科学院上海有机化学研究所 |
3β－羟基－5－胆烯酸酯类衍生物、合成方法及其用途
|
|
CN1098273C
(zh)
|
1999-11-12 |
2003-01-08 |
中国科学院上海有机化学研究所 |
高立体选择性的合成24r,25－和24s,25－二羟基甾体化合物
|
|
GB0000228D0
(en)
|
2000-01-06 |
2000-03-01 |
Phytopharm Plc |
Fluoro substituted sapogenins and their use
|
|
GB0019290D0
(en)
|
2000-08-04 |
2000-09-27 |
Symphar Sa |
Methods for inducing apolipoprotein E secretion
|
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
GB0107822D0
(en)
|
2001-03-28 |
2001-05-23 |
Phytopharm Plc |
Sapogenin derivatives their synthesis and use methods based upon their use
|
|
US20070197484A1
(en)
|
2001-05-03 |
2007-08-23 |
Ching Song |
Method of treating disorder related to high cholesterol concentration
|
|
PT1392713E
(pt)
|
2001-05-03 |
2008-01-25 |
Univ Chicago |
''agonistas de receptores x hepáticos''
|
|
WO2003039480A2
(en)
|
2001-11-08 |
2003-05-15 |
The University Of Chicago |
Method of treating disorder related to high cholesterol concentration
|
|
EP1461028A4
(en)
|
2001-12-07 |
2007-07-25 |
Univ California |
TREATMENT FOR AGE-RELATED MACULAR AGENCY
|
|
KR101130212B1
(ko)
|
2002-03-27 |
2012-04-13 |
파이토팜 피엘씨 |
사포게닌 및 그 유도체의 치료 방법 및 사용법
|
|
NZ547344A
(en)
|
2002-03-27 |
2007-11-30 |
Phytopharm Plc |
Therapeutic methods and uses of sapogenins and their derivatives
|
|
GB0216621D0
(en)
*
|
2002-07-17 |
2002-08-28 |
Imaging Res Solutions Ltd |
Imaging compounds
|
|
US6933312B2
(en)
|
2002-10-07 |
2005-08-23 |
Agouron Pharmaceuticals, Inc. |
Pyrazole derivatives
|
|
CA2506568A1
(en)
*
|
2002-11-22 |
2004-06-10 |
Merck & Co., Inc. |
2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists
|
|
WO2004055201A2
(en)
|
2002-12-13 |
2004-07-01 |
Bayer Healthcare Ag |
Cholesterol 24-hydroxylase (cyp46) as therapeutic target for the treatment of alzheimer's disease
|
|
FR2850023B1
(fr)
|
2003-01-17 |
2007-04-06 |
Mapreg |
Medicaments pour le systeme nerveux
|
|
US20050142192A1
(en)
|
2003-10-15 |
2005-06-30 |
Wyeth |
Oral administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and derivatives
|
|
GB0403889D0
(en)
|
2004-02-21 |
2004-03-24 |
Univ Edinburgh |
Uses of er-beta modulators
|
|
WO2006037016A2
(en)
|
2004-09-27 |
2006-04-06 |
The Regents Of The University Of California |
Novel therapy for treatment of chronic degenerative brain diseases and nervous system injury
|
|
US20070032464A1
(en)
|
2004-10-08 |
2007-02-08 |
Shutsung Liao |
Methods of treating cancers
|
|
JP2008518935A
(ja)
|
2004-11-01 |
2008-06-05 |
セオ ホン ユー |
筋萎縮性側索硬化症の神経退行を減少させるための方法及び組成物
|
|
EP1993558B1
(en)
|
2006-02-27 |
2014-07-30 |
The Regents of The University of California |
Oxysterol compounds and the hedgehog pathway
|
|
CN101164540A
(zh)
|
2006-08-03 |
2008-04-23 |
中山大学 |
海洋甾体化合物在制备治疗神经元损伤药物中的应用
|
|
GB0619860D0
(en)
|
2006-10-06 |
2006-11-15 |
Birkeland Innovasjon As |
Treatment of insulin resistance and disorders associated therewith
|
|
WO2008057468A1
(en)
|
2006-11-02 |
2008-05-15 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
IN2014DN02014A
(sr)
|
2006-11-21 |
2015-07-10 |
Umecrine Ab |
|
|
WO2009073186A1
(en)
|
2007-12-03 |
2009-06-11 |
The Regents Of The University Of California |
Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
|
|
KR101767849B1
(ko)
|
2007-06-20 |
2017-08-11 |
오스펙스 파마슈티칼스, 인코포레이티드 |
섬유증 저해제로서의 치환된 ｎ-아릴 피리디논
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
EP2207542A2
(en)
|
2007-11-06 |
2010-07-21 |
N.V. Organon |
A method of hormone suppression in humans
|
|
WO2009090063A1
(en)
|
2008-01-16 |
2009-07-23 |
Jado Technologies Gmbh |
Steroid sapogenin, androstane and triterpenoid sapogenin derivatives for the treatment and prevention of infectious diseases
|
|
WO2009094279A1
(en)
|
2008-01-25 |
2009-07-30 |
Merck & Co., Inc. |
Quinolizidinone m1 receptor positive allosteric modulators
|
|
MX2010012186A
(es)
|
2008-05-09 |
2011-02-22 |
Univ Emory |
Antagonistas del receptor nmda para el tratamiento de transtornos neuropsiquitricos.
|
|
WO2010065709A2
(en)
|
2008-12-03 |
2010-06-10 |
Amin Khan |
Hydroxamic acid derivatives, preparation and therapeutic uses thereof
|
|
WO2010075282A1
(en)
|
2008-12-22 |
2010-07-01 |
University Of Washington |
Molecular inhibitors of the wnt/beta-catenin pathway
|
|
WO2010088408A2
(en)
|
2009-01-28 |
2010-08-05 |
Emory University |
Subunit selective nmda receptor antagonists for the treatment of neurological conditions
|
|
US8829213B2
(en)
|
2009-07-29 |
2014-09-09 |
The University Of Chicago |
Liver X receptor agonists
|
|
WO2011028794A2
(en)
|
2009-09-01 |
2011-03-10 |
Lazarus Therapeutics, Inc. |
Treatment of huntington's disease with cycloserine and an nmda receptor antagonist
|
|
FR2953138B1
(fr)
|
2009-12-02 |
2015-10-16 |
Assist Publ Hopitaux Marseille |
Composes aminosteroidiens pour une application topique locale pour la decolonisation cutaneo-muqueuse de staphylococcus aureus
|
|
WO2011092127A1
(en)
|
2010-01-26 |
2011-08-04 |
Bayer Schering Pharma Aktiengesellschaft |
14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring
|
|
KR101692275B1
(ko)
|
2010-02-11 |
2017-01-04 |
노오쓰웨스턴 유니버시티 |
２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
|
|
US8247436B2
(en)
|
2010-03-19 |
2012-08-21 |
Novartis Ag |
Pyridine and pyrazine derivative for the treatment of CF
|
|
GB201008047D0
(en)
*
|
2010-05-14 |
2010-06-30 |
Ge Healthcare Ltd |
Method of synthesis
|
|
US20120035156A1
(en)
|
2010-08-09 |
2012-02-09 |
Daniela Alberati |
Combination of glyt1 compound with antipsychotics
|
|
US8969525B2
(en)
|
2010-11-09 |
2015-03-03 |
Enzo Life Sciences, Inc. |
Hydroxycholesterol immunoassay
|
|
WO2012142039A1
(en)
|
2011-04-15 |
2012-10-18 |
University Of North Dakota |
Combination of liver x receptor modulator and estrogen receptor modulator for the treatment of age-related diseases
|
|
WO2012166617A2
(en)
|
2011-05-27 |
2012-12-06 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
|
EP2736919A4
(en)
|
2011-07-29 |
2015-01-14 |
Univ California |
NEW 17-BETA-HETEROARYL-SUBSTITUTED STEROIDS AS MODULATORS OF GABAA RECEPTORS
|
|
SMT202300232T1
(it)
|
2011-09-08 |
2023-09-06 |
Sage Therapeutics Inc |
Steroidi neuroattivi, composizioni e relativi usi
|
|
AP2014007606A0
(en)
|
2011-10-07 |
2014-05-31 |
Takeda Pharmaceutical |
1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
|
|
ES2738526T3
(es)
|
2011-10-14 |
2020-01-23 |
Sage Therapeutics Inc |
Compuestos 19-norpregnano 3,3-disustituidos, composiciones y usos de los mismos
|
|
WO2013163455A2
(en)
|
2012-04-25 |
2013-10-31 |
The Regents Of The University Of California |
A drug screening platform for rett syndrome
|
|
US9737522B2
(en)
|
2012-08-09 |
2017-08-22 |
Emory University |
NMDA receptor modulators and uses related thereto
|
|
US20140149272A1
(en)
|
2012-08-17 |
2014-05-29 |
Trueex Group Llc |
Interoffice bank offered rate financial product and implementation
|
|
SG10201706063UA
(en)
|
2012-12-18 |
2017-09-28 |
Univ Washington |
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
|
|
WO2014115167A2
(en)
|
2013-01-23 |
2014-07-31 |
Sphaera Pharma Pvt. Ltd. |
Novel compounds of 11beta-hydroxy-steroids for use in mitochondria biogenesis and diseases associated with mitochondrial dysfunction or depletion
|
|
JP6419087B2
(ja)
|
2013-01-29 |
2018-11-07 |
アプティニックス インコーポレイテッド |
スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用
|
|
JP6255082B2
(ja)
*
|
2013-03-13 |
2017-12-27 |
セージ セラピューティクス， インコーポレイテッド |
神経刺激性ステロイドおよびその使用方法
|
|
CN105164161A
(zh)
|
2013-03-13 |
2015-12-16 |
萨奇治疗股份有限公司 |
神经活性类固醇、组合物、及其用途
|
|
AU2014324961A1
(en)
|
2013-09-25 |
2016-04-14 |
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences |
Highly potent glucocorticoids
|
|
RU2020111676A
(ru)
|
2014-02-08 |
2020-06-10 |
Дженентек, Инк. |
Способы лечения болезни альцгеймера
|
|
EP3157528B1
(en)
|
2014-06-18 |
2023-09-13 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
WO2016007762A1
(en)
|
2014-07-09 |
2016-01-14 |
Duke University |
Compositions and methods for the repair of myelin
|
|
US10016095B2
(en)
*
|
2014-10-03 |
2018-07-10 |
Progressive International Corporation |
Salad spinner
|
|
JP2017530982A
(ja)
|
2014-10-07 |
2017-10-19 |
セージ セラピューティクス， インコーポレイテッド |
神経刺激性化合物およびその使用方法
|
|
LT3319611T
(lt)
|
2015-07-06 |
2021-05-10 |
Sage Therapeutics, Inc. |
Oksisteroliai ir jų naudojimo būdai
|
|
SG10202002655VA
(en)
|
2015-07-06 |
2020-05-28 |
Sage Therapeutics Inc |
Oxysterols and methods of use thereof
|
|
EP4316591A3
(en)
|
2015-07-06 |
2024-04-24 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
GB2557875A
(en)
|
2015-09-02 |
2018-07-04 |
Univ Swansea |
Diagnostic methods and kits
|
|
WO2017173358A1
(en)
|
2016-04-01 |
2017-10-05 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
WO2017193046A1
(en)
|
2016-05-06 |
2017-11-09 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
JP6966486B2
(ja)
|
2016-07-07 |
2021-11-17 |
セージ セラピューティクス， インコーポレイテッド |
オキシステロールおよびその使用方法
|
|
ES2992037T3
(es)
|
2016-07-11 |
2024-12-05 |
Sage Therapeutics Inc |
Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización
|
|
EP3519422B1
(en)
|
2016-09-30 |
2022-08-31 |
Sage Therapeutics, Inc. |
C7 substituted oxysterols and these compounds for use as nmda modulators
|
|
MX2019004578A
(es)
|
2016-10-18 |
2019-10-09 |
Sage Therapeutics Inc |
Oxisteroles y metodos de uso de los mismos.
|
|
RU2019115112A
(ru)
|
2016-10-18 |
2020-11-24 |
Сейдж Терапьютикс, Инк. |
Оксистеролы и способы их применения
|
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
|
CN110945006A
(zh)
|
2017-06-23 |
2020-03-31 |
英特塞普特医药品公司 |
用于制备胆汁酸衍生物的方法和中间体
|
|
KR20200085837A
(ko)
|
2017-11-10 |
2020-07-15 |
마리누스 파마슈티컬스 인코포레이티드 |
유전적 간질 질환 치료에 사용하기 위한 가낙솔론의 용도
|
|
IL308273A
(en)
|
2021-05-04 |
2024-01-01 |
Sage Therapeutics Inc |
Neuroactive steroids for the treatment of mild cognitive impairment associated with Parkinson's disease
|
|
WO2022261510A1
(en)
|
2021-06-11 |
2022-12-15 |
Sage Therapeutics, Inc. |
Neuroactive steroid for the treatment of alzheimer's disease
|